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Summary 
Spindle cell carcinoma (SpCC) is a biphasic tumor composed of conventional 
squamous cell carcinoma and a malignant spindle cell component. SpCC expresses 
both epithelial and mesenchymal markers by immunohistochemical analysis. There is 
mounting evidence for sarcomatoid transformation from the epithelial component, 
supporting the theory that SpCC is a monoclonal neoplasm originating from a stem 
cell giving rise to both components. The loss of E-cadherin and the gain of N-cadherin 
expression are known as the “cadherin switching”. Cadherin switching is a major 
hallmark of epithelial-mesenchymal transition (EMT). EMT is a crucial process in 
cancer progression providing cancer cells with the ability to escape from the primary 
focus, to invade stromal tissues and to migrate to distant regions. Although E-cadherin 
down-regulation is well known in various cancers, there are a few studies on 
N-cadherin expression in cancer. Here, therefore, we investigated N-cadherin 
expression in the progression of head and neck SpCC. First we examined cadherin 
swithching in our established SpCC cell lines, SpCC-1 and SpCC-2. SpCC-1 and 
SpCC-2 cells were spindle in shape and showed cadherin switching. Moreover, we 
examined N-cadherin expression in 15 SpCC cases by immunohistochemistry. 
Although N-cadherin expression was not observed in non-neoplastic squamous 
epithelium, high expression of N-cadherin was observed in 10 of 15 SpCC cases. 
Interestingly, 6 of 7 SpCC cases with metastasis showed high expression of 
N-cadherin. In conclusion, our findings suggest that N-cadherin may play an important 
role in metastasis of SpCC in addition to the pathogenesis of SpCC of the head and 
neck. 
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Introduction 
Spindle cell carcinoma (SpCC) is a rare and peculiar biphasic malignant neoplasm 
that occurs mainly in the upper aerodigestive tract. SpCC has been referred to by a 
variety of names, including pseudosarcoma (1), carcinosarcoma (2) or pleomorphic 
carcinoma (3-5), which reflect the divergent interpretation of the sarcomatoid 
component as reactive or neoplastic, mesenchymal or epithelial. SpCC is thought of 
as a variant of squamous cell carcinoma, which shows biphastic proliferation of 
conventional SCC component and malignant spindle shape cells with sarcomatous 
appearance. It is generally accepted that the sarcomatoid cells are derived from 
squamous cells. We previously reported that the epithelial nature of the sarcomatoid 
component of SpCC was clearly revealed by a combination of immunohistochemical 
staining for keratins and electron microscopic demonstration of tonofilament-like 
filaments and/or desmosome-like structures (6). Moreover, we found co-expression of 
cytokeratins, vimentin and Wnt-5a in SpCC cell line (7). These our previous findings 
support the theory of epithelial origin and mesenchymal transition of SpCC. 
It has recently been suggested that epithelial-mesenchymal transition (EMT) 
might play an important role in the pathogenesis of SpCC (8-12). EMT is a crucial 
process in cancer progression, providing cancer cells with the ability to escape from 
the primary focus, to invade stromal tissues and to migrate to distant regions (13, 14). 
Cadherin switching, which is characterized by the loss of E-cadherin and the gain 
N-cadherin expression, is a major hallmark of EMT (13). Cadherins are a family of 
transmembrane proteins that mediate Ca2+-dependent cell-cell adhesion. Of the 
members of the cadherin family, E-cadherin is distributed widely and is the most 
important intercellular adhesion molecule in epithelial cells. Although E-cadherin is 
well documented as an invasive suppressor for cancer cells, the role of anomalously 
expressed N-cadherin in epithelial cells has only recently been identified more clearly 
(15). Unlike E-cadherin, N-cadherin is normally expressed in neuroectodermal and 
mesodermal-derived tissue and is involved in a lot of processes, such as cell-cell 
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adhesion, differentiation, embryogenesis, migration, invasion and signal transduction 
(15, 16). Aberrant expression of N-cadherin is considered to be associated with 
increased tumor progression in certain cancers (15). In particular, increased 
expression of N-cadherin and concomitant down-regulation of E-cadherin are 
suggested to be a feature of EMT in cancer (17). Previous report has shown that 
cadherin switching was observed in 19 of 30 SpCC cases. However, little is known 
about the role of aberrant expression of N-cadherin in SpCC. 
This study attempted to investigate the hypothesis that spindle cell 
phenotype might be related to the cadherins which form adherens junctions between 
cells, whether it is due to EMT representing invasive potential or simply a 
metaplastic/bidirectional differentiation process of the cancer cells. To find out the 
involvement, we examined the expression of N-cadherin and compared it with 
E-cadherin expression and clinico-pathological parameters in SpCC. 
 
Materials and methods 
Cell lines and cell culture 
SpCC cell line, SpCC-1 was previously established in our laboratory (Kudo et al., 
2006). SpCC-2 cell line was recently established from SpCC tissue sample. Tissue 
sample was obtained from a SpCC of a 32-year-old-Japanese female tumor in gingiva. 
The tissue sample was cut into small pieces and placed on 90-mm Petri dishes (3003, 
Falcon, Becton Dickinson, Franklin Lakes, NJ) with DMEM (Nissui Pharmaceutical 
Co., Tokyo, Japan) supplemented with 10% heat-inactivated FBS (Invitrogen) and 100 
U/ml penicillin-streptomycin (Gibco) under conditions of 5% CO2 in air at 37 ˚C.  
When these outgrowth cultures formed confluent monolayer, the cells were 
subcultured after enzymatic removal with 0.05 % trypsin-EDTA to passage 1 (P1). 
Then, we subcultured the cells with the same medium until over P100 and used for 
the following analyses. 
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Reverse transcription-polymerase chain reaction (RT-PCR) 
Total RNA was isolated and purified from cells by using RNeasy Mini Kit (Qiagen, 
Hilden, Germany). Preparations were quantified and their purity was determined by 
standard spectrophometric methods. cDNA was synthesized from 1μg total RNA 
according to the ReverTra Dash (Toyobo Biochemicals, Tokyo, Japan). Primer 
sequences included the following;  
human N-cadherin:  5’-GACAATGCCCCTCAAGTGTT-3’ (forward)  
5’-CCATTAAGCCGAGTGATGGT-3’ (reverse) 
human E-cadherin:  5’-TGCCCAGAAAATGAAAAAGG-3’ (forward)  
5’-GGATGACAGCGTGAGAGA-3’ (reverse) 
human Vimentin:  5’-CCCTCACCTGTGAAGTGGAT-3’ (forward)  
5’- TCCAGCAGCTTCCTGTAGGT-3’ (reverse) 
human GAPDH: 5’-ACAGTCAGCCGCATCTTCTT-3 (forward)  
5’-TTGATTTTGGAGGGATCTCG-3’ (reverse) 
Aliquots of total cDNA were amplified with 1.25 U of rTaq-DNA polymerase (Qiagen), 
and amplifications were performed in a PC701 thermal cycler (Astec, Fukuoka, Japan) 
for 25-35 cycles after an initial 30 sec denaturation at 94 ˚C, annealed for 30 sec at 60 
˚C, and extended for 1 min at 72 ˚C in all primers. The amplification reaction products 
were resolved on 1.2 % agarose/TAE gels, electrophoresed at 135 mV, and visualized 
by ethidium-bromide staining. 
 
Immunofluoresence 
SpCC-1 cells grown on coverslips were fixed in 4 % paraformaldehyde for 10 min at 
room temperature, rinsed three times with ice-cold PBS, and then permeabilized in 
0.1 % Triton X-100 in PBS for 15 min at room temperature. After rinsing three times 
with PBS, cover slips were incubated with the primary antibody in 10 % DMEM. We 
used N-cadherin monoclonal antibody (1:100; BD Transduction Laboratories) for 
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primary antibody and anti-mouse Alexa594 (1:1000; Molecular Probes, Eugene, OR) 
for secondary antibody. DNA was visualized by DAPI staining.  Immunostaining of 
cell preparations was recorded using an epifluorescence Zeiss Axioplan 2 (Zeiss Inc., 
Thorwood, NY) microscope attached to a CCD camera. 
 
Clinical data and paraffin-embedded tissue samples 
15 paraffin-embedded SpCC cases were selected from the Surgical Pathology 
Registry of Hiroshima University Hospital. Clinical details and lymph node metastasis 
were gathered from surgical records of the patients. Clinical data of the patients are 
summarized in Table 1. Among the 15 SpCC patients, 4 were males and 11 were 
females. At the time of diagnosis their age ranged from 32 to 98 years. Lymph node 
metastasis was observed in 7 cases. Tissues were fixed in 10% buffered formalin and 
embedded in paraffin. Informed consent was obtained from all patients for this study. 
 
Immunohistochemistry 
Unstained 4.5 ?m sections were cut from each paraffin block and de-paraffinized, 
rehydrated by routine techniques. Endogenous peroxidase activity was blocked with 
0.3% H2O2 in methanol in 30 minutes before doing retrieval antigen by microwave 
treatment in Tris-EDTA buffer pH 9.0 and in citrate phosphate buffer for N-cadherin 
and E-cadherin, respectively in 20 minutes. The sections were then incubated with 
protein block serum-free solution in 10 minutes. N-cadherin and E-cadherin 
monoclonal antibodies (BD Transduction Laboratories) were diluted in PBS (1:30 and 
1:150, respectively) and incubated for overnight at 4 ˚C. After washing three times by 
PBS, the sections were incubated with appropriate peroxidase-labeled secondary 
antibodies for 1 hour at room temperature. The sections were then labeled by 
diaminobenzidine and were counterstained with Mayer’s haematoxyline, dehydrated 
and mounted. Evaluation of immunostaining was based on proportion of stained 
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cancer cells and location of staining.  For N-cadherin, the samples were then divided 
into two groups; low (less than 20% of the cancer cells were stained) and positive 
(over 20% of the cancer cells were stained). E-cadherin was defined as preserved 
(over 80% of cancer cells exhibited positive staining similar to that in normal epithelial 
cells) and reduced (less than 80% of the cancer cells exhibited positive staining 
similar to that in normal epithelial cells). 
 
Statistical analysis 
Correlations between the expression pattern of N-cadherin and E-cadherin and the 
clinico-pathological features of SpCC were examined using Chi-square test. Statistical 




Establishment of SpCC cell line 
We established a SpCC cell line from a SpCC arisen in gingival of 
32-year-old female. The patient did not have a history of pre-existing squamous cell 
carcinoma and was treated by radical surgical excision without irradiation and 
chemotherapy.  Histologically, the tumor widely infiltrated into connective tissues, 
muscles and mandible with ulcer formation and metastasized to cervical lymph nodes. 
The tumor was mainly composed of pleomorphic spindle cells accompaning small 
areas of squamous cell carcinoma (Fig. 1A and 1D). The surface epithelium blended 
imperceptibly with the spindle cell component (Fig. 1B). SpCC cells metastasized to 
cervical lymph nodes (Fig. 1C). Immunohistochemically, the SpCC cells were positive 
for cytokeratins, detected by AE1/AE3 and CAM5.2 (Fig. 1E and 1F). SpCC cells were 
also positive for vimentin (Fig. 1G). ?-smooth muscle actin (?SMA), S100 and HMB45 
were negative in SpCC cells (Fig. 1H-J). The diagnosis of SpCC was made on the 
basis of these histological and immunohistochemical findings. We could subculture 
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this tumor cells up to 100 passages. We previously established another SpCC cell line, 
SpCC-1 (7). In similar to SpCC-1 cells, established SpCC cells (SpCC-2) showed 
spindle shape (Fig. 2A). SpCC-1 and SpCC-2 cells showed vimentin expression and 
loss of E-cadherin expression demonstrated by RT-PCR (Fig. 2B). Oral squamous cell 
carcinoma cell lines, Ca9-22 and Ho-1-U-1 cells showed E-cadherin expression. Then, 
we examined N-cadherin expression in SpCC cells. Both SpCC-1 and SpCC-2 cells 
showed high expression of N-cadherin (Fig. 2B) and N-cadherin expression was 
observed in the cytoplasm of SpCC cells (Fig. 2C). Thus, as we expected, cadherin 
switching was observed in SpCC cell lines. 
 
N-cadherin expression and its correlation with metastasis 
Next, we examined the expression of N-cadherin in 15 SpCC cases by 
immunohistochemistry. Although non-neoplastic mucous squamous epithelium was 
completely negative, high expression of N-cadherin was observed in SpCC cells (Fig. 
3A). High expression of N-cadherin was observed in 10 of 15 SpCC cases (Fig. 3B 
and Table 1). All cases showed reduced expression of E-cadherin in comparison with 
non-cancerous epithelial cells (data not shownTable 1). Interestingly, 6 of 7 SpCC 
cases with metastasis showed high expression of N-cadherin (Fig. 3C and Table 1). 
 
Discussion 
It is known that cellular changes resulting in a more mesenchymal-like state driven by 
EMT in cancer are thought to play a major role in tumor progression. The loss of 
E-cadherin and gain of N-cadherin expression are known as “cadherin switching” (13). 
Cadherin switching is thought to reflect an EMT, whereby tumor cells are released 
from E-cadherin-dependent cell-cell interations and acquire a motile phenotype 
through the induction of N-cadherin. In this study, we found the varying patterns of 
cadherin expression, associated with morphological transition from epithelial to 
spindle cell phenotype, loss of epithelial markers and expression of mesenchymal 
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markers. Cadherin switching was observed in all 2 SpCC cell lines and 10 of 15 SpCC 
cases. These features are reminiscent of EMT. Importantly, 6 of 7 SpCC cases with 
metastasis showed high expression of N-cadherin. As SpCC is rare to be found in 
head and neck, we could collect only a small group of patients. So far, there are a few 
studies on N-cadherin expression in SpCC (11, 12), and clinical benefit of N-cadherin 
expression is not clarified. Here we have shown that N-cadherin expression was well 
correlated with lymph node metastasis in SpCC. We suggest that N-cadherin may be 
a marker for prediction of metastasis. To prove this, further experiments using a large 
number of SpCC cases are required. 
It is well known that loss of E-cadherin expression is frequently found during 
tumor progression in most epithelial cancers (18).  We also previously demonstrated 
that methylation of E-cadherin is involved in invasion and metastasis in head and neck 
squamous cell carcinoma (19). On the other hand, aberrant de novo expression of 
N-cadherin has been noted in breast, prostate, and bladder cancers, where it parallels 
a down-regulation of E-cadherin and a decrease in tumor differentiation (20-22). As 
the result shown, N-cadherin expression was found in membrane and cytoplasm of 
SpCC cells by immunohistochemistry and immunofluorescence analysis. It has been 
shown that aberrant expression of N-cadherin in cancer cells can contribute to 
invasiveness and metastasis by making the cells more motile (23-25). It is interesting 
to examine the molecular mechanism of N-cadherin in metastasis of SpCC. It has 
been shown that cadherin switching is necessary for increased motility but is not 
required for the morphological changes that accompany EMT (26). In addition to 
N-cadherin and E-cadherin, other type of cadherins including P-cadherin and 
VE-cadherin are involved in EMT induction of cancer. P-cadherin was shown as one 
major component in reconfiguring mesenchymal cells with epithelial features by 
triggering GSK-3ß-mediated inactivation and cytoplasmatic translocation of Snail in 
oral squamous cell carcinoma (27). VE-cadherin was induced during EMT in 
mammary tumor cells and was aberrantly expressed in invasive human breast 
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carcinomas (28). However, mechanism of EMT induction in cancer is still unknown 
(29, 30). We suggest that SpCC cells can be a useful tool for understanding EMT 
induction in cancer. 
In conclusion, our study indicates N-cadherin may play an important role in 
metastasis of SpCC and EMT might play an important role in the pathogenesis of 
SpCC of the head and neck. 
  
Thao et al., 11 
REFERENCES 
1. Lane N. Pseudosarcoma (polypoid sarcoma-like masses) associated with 
squamous cell carcinoma of the mouth, faces and larynx: report of ten cases. 
Cancer 1957; 10: 19-41. 
2. Minckler DS, Meligro CH, Norris HT. Carcinosarcoma of larynx: case report with 
metastases of epidermoid and sarcomatous elements. Cancer 970; 26: 195-200. 
3. Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity. A clinicopathologic 
assessment of fifty-nine cases. Oral Surg 1980; 50: 523-534. 
4. Zarbo RJ, Crissman JD, Venkat H, Weiss MA. Spindle-cell carcinoma of the 
upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study 
of 18 biphasic tumors and comparison with seven monophasic spindle-cell 
tumors. Am J Surg Pathol 1986; 10: 741-753. 
5. Navarro P, Lozano E, Cano A (1993) Expression of E- or P-cadherin is not 
sufficient to modify the morphology and the tumorigenic behaviour of murine 
spindle carcinoma cells. J Cell Sci 105:923–934 
6. Ellis GL, Langloss JM, Heffner DK, Hymas VJ. Spindle-cell carcinoma of the 
aerodigestive tarct. An immunohistochemical analysis of 21 cases. Am J Pathol 
1987; 11: 335-342. 
7. Kudo Y, Ogawa I, Kitagawa M, Kitajima S, Siriwadena B. S. M. S, Aobara N, 
Matsuda C, Miyauchi M, Takata T (2006). Establishment and characterization of 
a spindle cell squamous carcinoma cell lines. J Oral Pathol Med. 35, 479-83. 
8. Islam S, Carey TE, Wolf GT et al (1996) Expression of N-cadherin by human 
squamous carcinoma cells induces a scattered fibroblastic phenotype with 
disrupted cell–cell adhesion. J Cell Biol 135:1643–1654 
9. Kim JB, Islam S, Kim YJ et al (2000) N-cadherin extracellular repeat 4 mediates 
epithelial to mesenchymal transition and increased motility. J Cell Biol 
151:1193–1206 
10. Chuang R, Crowe DL (2007) Understanding genetic progression of squamous 
cell carcinoma to spindle cell carcinoma in a mouse model of head and neck 
cancer. Int J Oncol 30:1279–1287 
11. Zidar N., Gale N., Kojc N., Volavsek M., Cardesa A., Alos L., Höfler H., 
Blechschmidt K and Becker K.F. Cadherin-catenin complex and transcription 
factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch. 453, 
267-274. 
Thao et al., 12 
12. Kojc N., Zidar N., Gale N., Poljak M., Fujs Komlos K., Cardesa A., Höfler H., 
Becker K.F. (2009). Transcription factors Snail, Slug, Twist, and SIP1 in spindle 
cell carcinoma of the head and neck. Virchows Arch. 454, 549-555.  
13. Gupta A. and Massagué J. (2006). Cancer metastasis: building a framework. Cell 
127, 679-695. 
14. Thiery J. (2003). Epithelial-mesenchymal transitions in development and 
pathologies. Curr. Opin. Cell Biol. 15, 740-746.  
15. Derycke L.D.M. and Bracke M.E. (2004). N-cadherin in the spotlight of cell-cell 
adhesion, differentiation, embryogenesis, invasion and signaling. Int. J. Dev. Biol. 
48, 463-476. 
16. Diamond M.E., Sun L., Ottaviano A.J., Joseph M.J. and Munshi H.G. (2008). 
Differential growth factor regulation of N-cadherin expression and motility in 
normal and malignant oral epithelium. J. Cell. Sci. 121, 2197-2207. 
17. Yilmaz M. and Christofori G. EMT, the cytoskeleton, and cancer cell invasion. 
Cancer Metastasis Rev. 28, 15-33. 
18. Cavallaro U. and Christofori G. (2004). Cell adhesion and signaling by cadherins 
and Ig-CAMs in cancer. Nat. Rev. Cancer 4, 118-132. 
19. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S., 
Miyauchi M. and Takata T. (2004). Invasion and metastasis of oral cancer cells 
require methylation of E-cadherin and/or degradation of membranous 
beta-catenin. Clin. Cancer Res. 10, 5455-5463. 
20. Han A.C., Soler A.P., Knudsen K.A., Wheelock M.J., Johnson K.R. and Salazar H. 
(1999). Distinct cadherin profiles in special variant carcinomas and other tumors 
of the breast. Hum. Pathol. 30, 1035-1039. 
21. Tomita K., van Bokhoven A., van Leenders G.J., Ruijter E.T., Jansen C.F., 
Bussemakers M.J. and Schalken J.A. (2000). Cadherin switching in human 
prostate cancer progression. Cancer Res. 60, 3650-3654. 
22. Giroldi L.A., Bringuier P-P., Shimazu T., Janssen K. and Schalken J.A. (1999). 
Changes in cadherin-catenin complexes in the progression of human bladder 
carcinoma. Int. J. Cancer 82, 70-76. 
23. Nieman M.T., Prudoff R.S., Johnson K.R. and Wheelock M.J. (1999). N-Cadherin 
Promotes Motility in Human Breast Cancer Cells Regardless of their E-Cadherin 
Expression. J. Cell. Biol. 147, 631-644. 
Thao et al., 13 
24. Hazan R.B., Kang L., Whooley B.P. and Borgen P.I. (1997). N-cadherin promotes 
adhesion between invasive breast cancer cells and the stroma. Cell Adhes. 
Commun. 4, 399-411. 
25. Van Aken E.H., De Wever O., Van Hoorde L., Bruyneel E., De Laey J.J. and 
Mareel M.M. (2003). Invasion of Retinal Pigment Epithelial Cells: N-cadherin, 
Hepatocyte Growth Factor, and Focal Adhesion Kinase Invest. Ophthalmol. Vis. 
Sci. 44, 463-442. 
26. Maeda M., Johnson K.R. and Wheelock M.J. (2004). Cadherin switching: 
essential for behavioral but not morphological changes during 
epithelium-to-mesenchyme transition. J. Cell. Sci. 118, 873-887. 
27. Bauer K., Dowejko A., Bosserhoff A.K., Reichert T.E. and Bauer R.J. (2009). 
P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma 
by GSK-3beta-mediated Snail phosphorylation. Carcinogenesis. 30, 1781-1788. 
28. Labelle M., Schnittler H.J., Aust D.E., Friedrich K., Baretton G., Vestweber D., 
Breier G. (2008). Vascular Endothelial Cadherin Promotes Breast Cancer 
Progression via Transforming Growth Factor β Signaling. Cancer Res. 68, 
1388-1397. 
29. Kalluri R., Weinberg R.A. (2009). The basics of epithelial-mesenchymal transition. 
J. Clin. Invest. 119, 1420-1428. 
30. Zeisberg M and Neilson E.G. (2009). Biomarkers for epithelial-mesenchymal 
transitions J. Clin. Invest. 119, 1429-1437 
Thao et al., 14 
FIGURE LEGENDS 
Figuer 1. Histologic and immunohistochemical findings of primary tumor of  
SpCC. (A) H&E staining; low magnification of SpCC (x40). Scale bar; 50 μm. (B) H&E 
staining; The surface epithelium of SpCC (x40). (C) Metastasis of SpCC to cervical 
lymph node (x40). (D) H&E staining; high magnification of SpCC (x200). Scale bar; 
250 μm. (E) Immunohistochemical staining; Expression of cytokeratins (AE1/AE3) in  
SpCC. (x200). (F) Immunohistochemical staining; Expression of cytokeratins 
(CAM5.2) in SpCC. (x200). (G) Immunohistochemical staining; Expression of vimentin 
in SpCC. (x200). (H) Immunohistochemical staining; Expression of ?SMA in SpCC. 
(x200). (I) Immunohistochemical staining; Expression of S100 in SpCC. (x200). (J) 
Immunohistochemical staining; Expression of HMB45 in SpCC. (x200). 
 
Figure 2. Cadhein switching in SpCC. (A) Morphology of SpCC cells. H & E staining 
of SpCC-1 and SpCC-2 cells was shown. (B) N-cadherin, E-cadherin and Vimentin 
mRNA expression was examined by RT-PCR in SpCC cells.  GAPDH expression 
was used as a positive control. (C) N-cadherin expression was examined by 
immunofluoresence analysis in SpCC-1 cells. After fixing with paraformaldehyde, 
SpCC-1 cells were stained with anti-N-cadherin antibody (green). Nuclei of the cells 
were stained by DAPI (blue). 
 
Figure 3. Immunohistochemical expression of N-cadherin in SpCC cases. (A) Left 
panel shows lower magnification (x40) and right panel shows higher magnification 
(x100). Scale Bar; 50 μm and 250 μm. (B) N-cadherin expression in 15 SpCC cases. 
Graph shows the number of SPCC cases with low or high expression of N-cadherin. 
(C) Correlation between N-cadherin expression and lymph node metastasis (negative 
or positive). Graph shows the number of SpCC cases with or without lymph node 
metastasis. 
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Table 1. Clinical data of SpCC patients and immunohistochemical results 
Case No. Sex Age Site Metastasis E-cadherin N-cadherin 
1 Male 50 Mandible Positive Reduced High 
2 Male 83 Tongue Negative Reduced Low 
3 Female 76 Tongue Positive Reduced High 
4 Female 82 Buccal mucosa Negative Reduced Low 
5 Female 75 Palate Negative Reduced Low 
6 Female 84 Mandible Positive Reduced High 
7 Female 60 Tongue Positive Reduced High 
8 Male 86 Tongue Negative Reduced High 
9 Female 69 Mandible Positive Reduced Low 
10 Female 98 Buccal mucosa Negative? Reduced Low 
11 Female 85 Buccal mucosa Negative? Reduced High 
12 Male 73 Mandible Negative? Reduced High 
13 Female 77 Tongue Positive Reduced High 
14 Female 85 Mandible Positive Reduced High 
15 Female 32 Maxilla Negative Reduced High 
 



